POSTER: A Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification

FLYER: Berkeley Lights Strategic Partnership

Berkeley Lights is ready to help you understand your unique cells and biological products better. Combining years of expertise and a highly advanced live-cell technology, we can develop a high-throughput functional screening workflow that streamlines your processes and improves your products.

INFO SHEET: TechAccess Subscriptions

TechAccess Subscriptions provide access to Berkeley Lights’ revolutionary workflows no matter
the size of your lab, your customer base, or budget.

Datasheet: BLI Software Suite 2.4

Berkeley Lights Software Suite 2.4 upgrade is loaded with customer-requested features that focus on reduced touchpoints and more intuitive data analysis.

eBook: How to Get More Molecules to the Clinic Faster with Automated Cell Line Development

Learn how our Opto CLD workflow can help remove the bottleneck from traditional cell line development.

Webinar: Bring Product Quality Assessment into Early Clone Selection with Opto™ Cell Line Development

CHO cell line selection represents a painful bottleneck in biotherapeutic development, particularly for complex molecules like bispecifics. At BPI Europe Digital Week 2021, Renee Tobias discussed how the Opto™ CLD workflow on the Beacon® system can help through accelerating early CLD by integrating high throughput cell sorting, cloning, culture, productivity, growth, and product quality assays into a single, 5-day automated process.

Webinar: Abveris on Lessons Learned from 2+ Years of Discovering Functional Antibodies on the Beacon

At PEGS EU 2021, Abveris CEO Tracey Mullen shared a few important lessons learned through using the Beacon system for antibody discovery. She discussed how the Berkeley Lights Platform has enabled Abveris to focus on deeply screening their antibodies upstream and only pulling forward the most qualified and functionally relevant antibodies for re-expression.

APP NOTE: Discover Lead Molecules Against Difficult Targets in 1 Week with Opto® Plasma B Discovery 4.0

Find out how the Opto Plasma B Discovery 4.0 workflow can be used to access broad plasma cell diversity, rapidly down-select lead candidates with functional profiling, and sequence and re-express >1,000 functionally characterized antibodies in 1 week.

Webinar: Opto™ Plasma B Discovery 4.0 Fireside Chat

Join members of our Opto Plasma B Discovery 4.0 development team for a panel discussion about our latest antibody discovery workflow.

Customer Spotlight: Amgen on the Berkeley Lights Platform

Philip Tagari, VP Therapeutic Discovery, Amgen, discusses how the Berkeley Lights’ platform has transformed the way Amgen approaches antibody discovery and cell line development.

Brochure: Get to the Clinic First with Best-In-Class Antibody Therapeutics

Find out how Opto™ Plasma B Discovery on the Beacon optofluidic system allows Pharma to succeed against difficult targets and deliver best-in-class antibody therapeutics.

Brochure: Lead Molecules Against Any Target. At Record Pace.

Find out how Opto™ Plasma B Discovery on the Beacon optofluidic system allows CROs to scale their business and rapidly deliver lead molecules even against difficult targets.

Webinar: Rapid Discovery of Functional Antibodies for SARS-CoV-2

Dr. Robert Carnahan, Ph.D., discusses how the Beacon system helped enable the rapid discovery functional antibodies against SARS-CoV-2.

Datasheet: Adherent Cell Kit

Learn more about how the Adherent Cell Kit enables the isolation, growth, monitoring and recovery of adherent cells on the Beacon® and Lightning™ Optofluidic systems.

App Note: Bring Product Quality Assessment into Early Clone Selection with the Opto™ Assure Aggregation Assay

Read this application note to learn more about how to get early, multi-parameter assessment of clones with the Opto Assure assay series.

Customer Spotlight: Genovac on Antibody Discovery

Find out how Genovac is delivering 10-fold more lead candidates against difficult targets.

Brochure: Get to Market Faster with the Opto CLD Workflow

Find out how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development to let BioPharma get more molecules to the clinic faster. 

Brochure: Increase CDMO Revenue with the Opto CLD Workflow

Find our how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development and allows CDMOs to scale operations and drive new business.